NU SKIN ENTERPRISES, INC. (NYSE:NUS) Files An 8-K Results of Operations and Financial Condition
Item 2.02
Results of Operations and Financial Condition.
|
Item 7.01 |
Regulation FD Disclosure. |
At an event with outside parties on January 31, 2019, a representative of Nu Skin Enterprises, Inc. (the “Company”) inadvertently discussed an estimate of the Company’s revenue for the fiscal year ended December 31, 2018. The Company hereby estimates that its revenue for the fiscal year ended December 31, 2018 was approximately $2.68 billion. The Company will provide additional information and context when it releases its 2018 fourth-quarter and annual earnings results on February 13, 2019.
The Company’s results are preliminary and remain subject to the completion of the Company’s customary close and review procedures. Material adjustments may arise between the date of this Current Report on Form 8-K and the dates on which the Company announces its full 2018 annual results and files its Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
The information furnished to these Items 2.02 and 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
Important Information Regarding Forward-Looking Statements: This report’s disclosure of estimated revenue for the fiscal year ended December 31, 2018 is a forward-looking statement within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, and it represents the Company’s current expectations and beliefs. The forward-looking statement involves risks and uncertainties that could cause actual results and outcomes to differ materially from the forward-looking statement expressed herein, including the Company’s procedures and potential adjustments referenced above and other risks and uncertainties that are set forth in the documents the Company has filed with the Securities and Exchange Commission. The forward-looking statement sets forth the Company’s beliefs as of the date that such information was first provided, and the Company assumes no duty to update the forward-looking statement contained in this report to reflect any change except as required by law.
About NU SKIN ENTERPRISES, INC. (NYSE:NUS)
Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum. The Pharmanex product line includes ageLOC TR90 weight management and body shaping system, and LifePak and ageLOC R2 nutritional supplements. The Company has operations in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). It is focused on offering ageLOC Youth nutritional supplement and ageLOC Me personalized skin care system. The Company also offers household products and technology services.
